Onkologie. 2019:13(2):59-62 | DOI: 10.36290/xon.2019.011

What's new in colorectal cancer?

Co je nového u kolorektálního karcinomu?

Klinika onkologie a radioterapie, Fakultní nemocnice Hradec Králové

We are wittnesses of scientific progress that push forward the knowledge even in the research on cancer. Computing technology and methods of molecular biology and genetics follow this progress and reveal new possibilities in the research of pathogenesis, diagnostics and also treatment of malignant tumours. Colorectal carcinoma is now worldwide the second cause of death in all malignancies (1). Its incidence is often connected to western-like lifestyle. However, exact causes are still hidden in the mist of uncertainties and doubts. Survival of the patients with metastatic colorectal cancer doubled in last twenty years (2). In connection to the huge effort and financial costs these results do not meet our expectations and the way to find the absolute cure of this tumour is still long and challenging. We still do not have universal treatment for all oncologic patients, also the rediscovery of immunotherapy has its limitations. But in the future not far away, we will hopefuly find it. Taking into account financial sources for research, development and ongoing treatment of oncologic diseases and colorectal cancer specifically, all efforts are put in to individualize the attitude and then improve the final results. What is the last progress and what could we expect in near future?

Keywords: colorectal carcinoma, prevention, liquid biopsy, BRAF, immunotherapy

Published: April 5, 2019  Show citation